A Working Group of the American Academy of Dermatology classified the severity of psoriatic arthritis based on its clinical impact and therapeutic requirements.
Parameters:
(1) therapeutic requirements
(2) disability
Therapy |
Disability |
Severity |
adequate response to NSAIDS |
none to minimal |
mild |
disease modifying anti-rheumatic drugs (DMARDs) or tumor necrosis factor (TNF) blocker; does not respond to NSAIDS |
affects activities of daily living (ADL); some impairment of mental function and/or physical function |
moderate |
DMARDs AND (TNF blockers or other biologic therapies); does not respond to monotherapy |
unable to perform activities of daily living; significant impairment of mental and/or physical function |
severe |
Purpose: To classify the severity of a patient's psoriatic arthritis based on its impact on the patient's life and therapeutic requirements.
Specialty: Immunology/Rheumatology
Objective: risk factors, laboratory tests, severity, prognosis, stage, response to therapy
ICD-10: L40.5, M07, M09.0,